XT
AYTU icon

XTX Topco’s AYTU BioPharma AYTU Stock Holding History

XTX Topco’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Sell
21,416
-166
-0.8% -$392 ﹤0.01% 3736
2026
Q1 		$58.9K Sell
21,582
-4,278
-17% -$10.9K ﹤0.01% 3273
2025
Q4 		$67.2K Buy
+25,860
New +$58K ﹤0.01% 2754

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco's AYTU Position: Q2 2026 in Review

XTX Topco reduced its AYTU BioPharma (AYTU) stake by 0.77% in Q2 2026, selling an estimated $392 and leaving 21,416 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #3736.

XTX Topco first reported a position in AYTU in Q4 2025 and has held it in 3 quarters since. The position peaked at $67.2K in Q4 2025. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • XTX Topco held 21,416 shares of AYTU BioPharma worth $46K as of Q2 2026.
  • XTX Topco sold 166 AYTU BioPharma shares in Q2 2026, an estimated $392.
  • AYTU BioPharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3736 holding.
  • XTX Topco first reported a position in AYTU BioPharma in Q4 2025 and has held it in 3 quarters since.
  • XTX Topco's AYTU BioPharma position peaked at $67.2K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.